We are live on ! Find out more
AVNS icon

Avanos Medical

317 hedge funds and large institutions have $1.98B invested in Avanos Medical in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 79 increasing their positions, 99 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,918% more call options, than puts

Call options by funds: $2.25M | Put options by funds: $56K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

3% more capital invested

Capital invested by funds: $1.93B → $1.98B (+$52.2M)

0.39% more ownership

Funds ownership: 95.08%95.47% (+0.39%)

6% less funds holding

Funds holding: 338317 (-21)

20% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 99

28% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 54

Holders
317
Holders Change
-21
Holders Change %
-6.21%
% of All Funds
6.89%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
39
Increased
79
Reduced
99
Closed
54
Calls
$2.25M
Puts
$56K
Net Calls
+$2.19M
Net Calls Change
-$2.35M
Name Holding Trade Value Shares
Change
Change in
Stake
BC
126
Blackhill Capital
New Jersey
$370K
Citigroup
127
Citigroup
New York
$366K +$229K +5,356 +176%
COPPSERS
128
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$365K +$471 +11 +0.1%
MCIM
129
Meadow Creek Investment Management
Georgia
$363K
Public Employees Retirement Association of Colorado
130
Public Employees Retirement Association of Colorado
Colorado
$362K
NMERB
131
New Mexico Educational Retirement Board
New Mexico
$358K -$59.9K -1,400 -15%
Credit Agricole
132
Credit Agricole
France
$357K -$351K -8,195 -50%
RB
133
Rodgers Brothers
Pennsylvania
$356K -$1.33K -31 -0.4%
BNP Paribas Financial Markets
134
BNP Paribas Financial Markets
France
$356K -$78.3K -1,830 -18%
XK
135
Xact Kapitalforvaltning
Sweden
$354K
RJFSA
136
Raymond James Financial Services Advisors
Florida
$351K +$344K +8,048 New
LTFS
137
Ladenburg Thalmann Financial Services
Florida
$344K +$30.1K +704 +10%
BAM
138
Blueshift Asset Management
New Jersey
$344K +$338K +7,895 New
Squarepoint
139
Squarepoint
New York
$341K +$335K +7,821 New
AB
140
Amalgamated Bank
New York
$324K +$23.1K +539 +8%
CCIA
141
Campbell & Co Investment Adviser
Maryland
$321K +$315K +7,353 New
WAM
142
Wallington Asset Management
Indiana
$320K -$3.68K -86 -1%
IG
143
ING Group
Netherlands
$318K +$428 +10 +0.1%
EIM
144
Essex Investment Management
Massachusetts
$317K -$434K -10,141 -58%
Stifel Financial
145
Stifel Financial
Missouri
$316K +$313K +7,320 New
USAA
146
United Services Automobile Association
Texas
$307K -$119K -2,783 -28%
AG
147
Advisor Group
Arizona
$306K -$31.3K -731 -9%
US Bancorp
148
US Bancorp
Minnesota
$301K -$6.12K -143 -2%
TRSOTSOK
149
Teachers Retirement System of the State of Kentucky
Kentucky
$300K -$34.2K -800 -10%
Bank of Montreal
150
Bank of Montreal
Ontario, Canada
$297K +$165K +3,858 +131%

AVNS Hedge Fund Activity: Q2 2019 in Review

317 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2019, worth a combined $1.98B — up 2.7% from $1.93B a quarter earlier.

Sellers outnumbered buyers: 54 funds closed out of AVNS and 39 opened new positions — a net loss of 15 holders — while 99 trimmed existing stakes and 79 added.

The largest buyer was RGM Capital, adding an estimated $30.3M. The largest seller was Wells Fargo, cutting an estimated $24.1M.

  • 317 institutional investors held Avanos Medical (AVNS) as of Q2 2019, down from 338 in Q1 2019.
  • Funds reported $1.98B of Avanos Medical stock for Q2 2019, up 2.7% quarter-over-quarter.
  • 39 funds opened new Avanos Medical positions in Q2 2019 and 54 closed out, a net change of -15 holders.
  • The largest Avanos Medical buyer in Q2 2019 was RGM Capital, an estimated $30.3M added.
  • The largest Avanos Medical seller in Q2 2019 was Wells Fargo, an estimated $24.1M sold.

Based on aggregated 13F filings for Q2 2019.